Verified peer comparison
Takeda Pharmaceutical vs Mizuho Financial Group, Inc. Sponosred Financial Comparison
Direct answer
Takeda Pharmaceutical and Mizuho Financial Group, Inc. Sponosred are compared on the same basis.
The comparison uses 2026 results reported in JPY.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Takeda Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Takeda Pharmaceutical Revenue
- 4,777,450,268,000 JPY
- Mizuho Financial Group, Inc. Sponosred Revenue
- 9,490,330,969,000 JPY
- Takeda Pharmaceutical Operating income
- 573,042,315,000 JPY
- Mizuho Financial Group, Inc. Sponosred Operating income
- 1,720,121,514,000 JPY